Background Several studies have compared the discriminative performances of CHA 2 DS 2-
VASc and ATRIA scores, but the results are still disputed. Therefore, we aimed to explore …

Essentials• CHADS 2 and CHA 2 DS 2‐VASc scores are used to predict stroke in atrial
fibrillation (AF).• These scores were calculated for a large cohort from the largest healthcare …

Background This large‐scale observational study on negative events in a real‐world setting
investigated Japanese patients with atrial fibrillation who were not on anticoagulants. This …

Background and Purpose—The CHA2DS2-VASc stroke score (congestive heart failure,
hypertension, age≥ 75 (doubled), diabetes mellitus, prior stroke or transient ischemic attack …

Two validated scoring systems for predicting embolic risk, CHADS2 and CHA2DS2-VASc,
contribute to optimizing antithrombotic prescription practices in patients who have atrial …

Background and Purpose—Atrial fibrillation (AF) is an independent risk factor for stroke.
Recent studies have demonstrated that the CHA2DS2-VASc scheme is useful for selecting …

Background Early identification of individuals who are at risk of developing atrial fibrillation
(AF) and ischemic stroke may enable a closer surveillance and thus prompt initiation of oral …

Abstract Aims The CHA2DS2-VASc score is a modification of the CHADS2 score that aims to
improve stroke risk prediction in patients with atrial fibrillation (AF) by adding three risk …

Aims Better stroke risk prediction is needed to optimize the anticoagulation decision in atrial
fibrillation (AF). The ATRIA stroke risk score (ATRIA) was developed and validated in two …

Essentials• The widely recommended CHA2DS2‐VASc shows conflicting results in
contemporary validation studies.• We performed a systematic review and meta‐analysis of …